A Minnesota-based company is recalling more than 348,000 defibrillators over concerns that they may not work. Medtronic, which has its executive headquarters based in Minneapolis, initiated the recall ...

Please provide your email address to receive an email when new articles are posted on . Medtronic recalled ICDs and CRT-Ds with a glassed feedthrough made after Oct. 13, 2017 due to risk for low- or ...

Medtronic plc’s MDT cardiac resynchronization therapy defibrillators (CRT-Ds) recently won the CE Mark approval for undergoing 3 Tesla (T) magnetic resonance imaging (MRI) scans. Notably, Medtronic’s ...

Almost exactly a year after beginning a recall of some of its implantable defibrillator devices that were found to potentially emit electrical pulses below their programmed strength, Medtronic has ...

A trio of cardiovascular companies put forward data this week bolstering their transcatheter aortic valve replacement programs. Medtronic, Edwards Lifesciences and Abbott presented studies at the ...

CHICAGO (Reuters) - Patients with mild to moderate heart failure benefited from an implanted Medtronic Inc device that combines a pacemaker to coordinate pumping with a defibrillator that shocks the ...

Medtronic Plc (NYSE:MDT) has recalled certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) with glassed feedthrough. The FDA has ...

The Food and Drug Administration approved Dublin-based Medtronic’s Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator for patients with heart failure. The Claria MRI CRT-D contains ...

CHICAGO (Reuters) - Medtronic Inc said on Tuesday a study of device therapy in patients with mild heart failure missed its primary goal on a measure of disease progression, but some patients saw their ...

New data from Medtronic's (Minneapolis) Adaptive CRT trial show a 61% lower risk of atrial fibrillation (AF)-related problems in patients who receive a cardiac resynchronization therapy-defibrillator ...